Nkarta share price logo

Nkarta

NASDAQ: NKTX

$2.61

-0.01

(-0.38%)

Live

as on

Nkarta Stock Performance

as on October 1, 2026 at 5:08 am IST

  • Day's Low

    Day's High

    $2.55
    $2.69
    downward going graph

    2.30%

    Downside

    3.07%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.70
    $3.72
    downward going graph

    34.87%

    Downside

    42.53%

    Upside

    downward going graph

Nkarta share price movements today

Previous Close
$2.62
Open
$2.65
Volume
186.7K
Market Cap
$191.2M
Day's Low - High
$2.55 - $2.69
52 Week Low - High
$1.70 - $3.72

Nkarta Historical Returns

1 Month Return
-5.07 %
3 Month Return
-7.42 %
1 Year Return
+ 26.57 %
3 Year Return
+ 88.49 %
5 Year Return
-90.58 %

Nkarta Stock Fundamentals & Key Indicators

Check Nkarta market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$191.2M

EPS (TTM)

-1.57

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.7

Industry PE ratio

-2.66

PEG Ratio

0.19

EBITDA

-107.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-39.64%

Nkarta vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nkarta with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$191.2M-90.58%-1.700.00%0.00%
StrongBuy$43.2B643.29%-22.770.00%0.00%
Neutral$78.8B-47.13%-24.72-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$81.1B24.01%17.9684.86%0.49%

Stock Returns calculator for Nkarta Stock including INR - Dollar returns

The Nkarta stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Nkarta investment value today

Current value as on today

₹1,36,006

Returns

₹36,006

(+36.01%)

Returns from Nkarta Stock

₹26,087 (+26.09%)

Dollar Impact

₹9,919 (+9.92%)

Analyst Recommendation on Nkarta Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Nkarta. Average target price of $10.83

Nkarta Share Price Target

Get share price movements and forecasts by analysts on Nkarta.

What analysts predicted

75.9%UPSIDE

Target Price

$10.83

Current Price

$2.61

Analyzed by

3 Analysts

High

$11

Target

$10.83

Low

$10

Nkarta target price $10.83, a slight upside of 75.9% compared to current price of $2.61. According to 3 analysts rating.

Indian Investors' Interest in Nkarta Stock

Search interest for Nkarta Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-37% versus previous 30 day period

Nkarta Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-2
-
-
-
-
-
-
-
-2
-
Operating Income
-32
-30
-33
-30
-36
-27
-27
-30
-30
-43
EBITDA
-27
-22
-25
-23
-29
-20
-19
-25
-25
-37
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
2
2
2
2
2
2
2
2
2
2
Income Before Tax
-29
-24
-28
-25
-31
-22
-21
-27
-27
-40
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-29
-24
-28
-25
-31
-22
-21
-27
-27
-40
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Nkarta Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
0
-
-
-
-
-
-
Gross Profit
2
0
-
-
-
-5
-
-9
Operating Income
0
-22
-51
-86
-118
-131
-128
-121
EBITDA
0
-20
-50
-84
-105
-120
-99
-94
Interest Expense
-
0
-
-
5
-
-
-
Depreciation
0
0
0
1
2
5
9
9
Income Before Tax
0
-21
-91
-86
-113
-117
-108
-104
Income Tax Expense
-
1
-
-
-
-
-
-
Net Income
0
-21
-91
-86
-113
-117
-108
-104
Net Profit Margin
35.08%
85.08%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Nkarta Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-29
-24
-28
-25
-31
-22
-21
-27
-27
-40
Operating Cash Flow
-28
-21
-24
-24
-29
-18
-18
-21
-28
-24
Investing Cash Flow
21
-107
-38
-4
54
19
25
1
15
21
Financing Cash Flow
226
0
0
0
-
0
-
0
0
0
Change in Cash
219
-129
-63
-29
24
0
6
-20
-12
-2

Nkarta Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-21
-91
-86
-113
-117
-108
-104
Operating Cash Flow
-5
-18
-43
-67
-57
-86
-99
-88
Investing Cash Flow
0
-18
-210
32
-184
79
-129
100
Financing Cash Flow
0
49
329
1
219
0
226
0
Change in Cash
-5
12
76
-34
-22
-6
-3
11

Global Institutional Holdings in Nkarta

Check out the Institutions with significant holdings in Nkarta.

Funds
Holdings
Peter Kolchinsky
15.09%
Vanguard
3.45%
VANGUARD INDEX FUNDS
2.76%
iShares
2.37%
WASATCH FUNDS TRUST
2.08%

Insights on Nkarta

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, NKTX stock has moved up by 31.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 687.7% return, outperforming this stock by 661.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 97.0% return, outperforming this stock by 8.5%

About Nkarta

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
OrganisationNkarta
Headquarters1150 Veterans Boulevard, South San Francisco, CA, 94080, US
IndustryBiotechnology
CEOPaul J. Hastings

Key Management of Nkarta

Name

Title

Mr. Paul J. Hastings

CEO & Director

Dr. Nadir Mahmood Ph.D.

President and Principal Accounting & Financial Officer

Dr. Shawn Rose M.D., Ph.D.

Chief Medical Officer and Head of Research & Development

FAQs

What is Nkarta share price today?

Nkarta share price today is $2.61 as on . Nkarta share today touched a day high of $2.69 and a low of $2.55.

What is the 52 week high and 52 week low for Nkarta share?

Nkarta share touched a 52 week high of $3.72 on and a 52 week low of $1.70 on . Nkarta stock price today i.e. is trending at $2.61,which is 29.84% down from its 52 week high and 53.53% up from its 52 week low.

What is Nkarta's market capitalisation today?

Nkarta market capitalisation is $0.00T as on .

How to invest in Nkarta Stock (NKTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nkarta on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Nkarta Stock (NKTX) from India?

Indian investors can start investing in Nkarta (NKTX) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Nkarta stock (as per the Rupee-Dollar exchange rate as on ). Based on Nkarta share’s latest price of $2.61 as on September 30, 2026 at 11:38 pm IST, you will get 3.8314 shares of Nkarta. Learn more about fractional shares .

What are the returns that Nkarta has given to Indian investors in the last 5 years?

Nkarta stock has given -90.58% share price returns and 29.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?